Qudexy, Topamax, Topamax Sprinkle, Trokendi (topiramate) is a small molecule pharmaceutical. Topiramate was first approved as Qudexy on 1996-12-24. It is used to treat bipolar disorder, epilepsy, infantile spasms, lennox gastaut syndrome, and pain amongst others in the USA. It is known to target carbonic anhydrase 7, carbonic anhydrase 1, carbonic anhydrase 12, and carbonic anhydrase 4. Topamax's patents are valid until 2033-03-19 (FDA).
|Trade Name||Qudexy, Topamax, Topamax Sprinkle, Trokendi|
|Indication||bipolar disorder, epilepsy, infantile spasms, lennox gastaut syndrome, pain, partial epilepsies, tonic-clonic epilepsy|